Financials / Press Releases

INVESTOR RELATIONS

BIOQUAL, Inc. is a public company traded on the OTC Markets Group – Symbol BIOQ.

BIOQUAL, Inc.’s Transfer Agent:

Computershare, Inc.
480 Washington Boulevard
Jersey City, New Jersey 07310
www.computershare.com

CONTACT:

Mark Lewis
President / Chief Executive Officer
BIOQUAL, Inc.
Phone: (240) 404-7654 ext. 1012

BIOQUAL Presents Unaudited Financial Statements and Management’s Discussion and Analysis for the Quarterly Period ending August 31, 2020 [Updated 10/21/20]

  

Press Release, BIOQUAL, Inc. Announces Unaudited Financial Results for FY 2021 1st Quarter [10/21/20]

 

Press Release, 09/21/20, BIOQUAL, Inc. and Subsidiary Announces Publication of an Investigational COVID-19 Vaccine Candidate that Prevents Severe Clinical Disease in Animals

 

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2020 [Updated 09/14/20]

 

BIOQUAL, Inc. and Subsidiary Presents Audited Consolidated Financial Statements for Fiscal Year 2020 [Updated 09/14/20]

 

Press Release, 09/15/20, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2020 and Declares Dividend

 

BIOQUAL Announces Publication New England Journal Medicine. August, 10, 2020

 

Press Release, BIOQUAL, Inc. July 31, 2020 Rockville

 

Press Release, BIOQUAL, Inc. Announces Release of Two COVID-19 Research Publications [05/20/20]

 

BIOQUAL Presents Unaudited Financial Results for FY 2020 Third Quarter Ending February 29, 2020 [Updated 04/21/20]

 

Press Release, BIOQUAL, Inc. Presents Financial Results for FY 2020 Third Quarter [Updated 04/21/20]

 

Press Release, 04/07/20, Scheduling of Annual Shareholder Meeting

 

Press Release, 03/31/20, BIOQUAL Announces COVID-19 Vaccine Testing

 

BIOQUAL Presents Financial Results for FY 2020 Second Quarter Ending November 30, 2019 [Updated 01/21/20]

 

Press Release, 01/21/20, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Second Quarter of Fiscal Year 2020 [Updated 01/22/19]

 

Mark Lewis Letter To Shareholders [09/20/19]

 

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2019 [Updated 09/13/19]

 

BIOQUAL, Inc. and Subsidiary Presents Audited Consolidated Financial Statements for Fiscal Year 2019 [Updated 09/13/19]

 

Press Release, 09/13/19, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2019 and Declares Dividend

 

In Memoriam, J. Thomas August, M.D. [Updated 02/22/19]

 

Press Release, 02/22/19, Death of J. Thomas August, M.D., a Member of the Board of Directors of BIOQUAL, Inc.

 

Mark Lewis Letter To Shareholders [10/18/18]

 

Press Release, 09/11/18, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2018 and Declares Dividend

 

BIOQUAL, Inc. and Subsidiary Presents Audited Financial Statements ending May 31, 2018 and 2017 [Updated 09/11/18]

 

Management’s Discussion and Analysis for the Fiscal Year ended 05/31/2018 [Updated 09/11/18]

 

 

 

 

Please send mail to itdept@bioqual.com with questions or comments about this website.